Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
12.89
-0.07 (-0.54%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Entrada Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 464 | 369 | 612 | 503 | 424 | 534 | |
| Market Cap Growth | 64.88% | -39.78% | 21.70% | 18.72% | -20.71% | - | |
| Enterprise Value | 219 | 94 | 224 | 219 | 236 | 610 | |
| Last Close Price | 12.89 | 10.28 | 17.29 | 15.09 | 13.52 | 17.12 | |
| PE Ratio | - | - | 9.33 | - | - | - | |
| PS Ratio | 18.25 | 14.50 | 2.90 | 3.90 | - | - | |
| PB Ratio | 1.52 | 1.20 | 1.43 | 2.08 | 1.99 | 1.79 | |
| P/TBV Ratio | 1.52 | 1.20 | 1.43 | 2.08 | 1.99 | 1.79 | |
| P/FCF Ratio | - | - | - | 3.75 | - | - | |
| P/OCF Ratio | - | - | - | 3.60 | - | - | |
| EV/Sales Ratio | 8.63 | 3.71 | 1.06 | 1.69 | - | - | |
| EV/EBITDA Ratio | - | - | 4.41 | - | - | - | |
| EV/EBIT Ratio | - | - | 4.77 | - | - | - | |
| EV/FCF Ratio | - | - | - | 1.63 | - | - | |
| Debt / Equity Ratio | 0.17 | 0.17 | 0.14 | 0.28 | 0.12 | - | |
| Debt / EBITDA Ratio | - | - | 0.92 | 4.68 | - | - | |
| Debt / FCF Ratio | - | - | - | 0.51 | - | - | |
| Net Debt / Equity Ratio | -0.80 | -0.80 | -0.84 | -1.17 | -0.77 | -0.97 | |
| Net Debt / EBITDA Ratio | 1.61 | 1.61 | -7.10 | 883.92 | 1.71 | 5.82 | |
| Net Debt / FCF Ratio | 1.89 | 1.89 | 8.07 | -2.11 | 1.68 | 5.25 | |
| Asset Turnover | 0.06 | 0.06 | 0.42 | 0.36 | - | - | |
| Quick Ratio | 12.20 | 12.20 | 10.78 | 2.26 | 8.62 | 43.32 | |
| Current Ratio | 12.53 | 12.53 | 11.15 | 2.33 | 9.55 | 44.46 | |
| Return on Equity (ROE) | -39.13% | -39.13% | 19.56% | -2.94% | -37.01% | -30.19% | |
| Return on Assets (ROA) | -21.58% | -21.58% | 5.90% | -0.55% | -21.79% | -18.29% | |
| Return on Invested Capital (ROIC) | -244.42% | -241.38% | 350.11% | 41.75% | -233.30% | -1165.02% | |
| Return on Capital Employed (ROCE) | -44.20% | -44.20% | 9.70% | -1.00% | -42.30% | -17.10% | |
| Earnings Yield | -30.98% | -38.99% | 10.72% | -1.33% | -22.33% | -9.57% | |
| FCF Yield | -27.92% | -35.14% | -7.30% | 26.68% | -22.82% | -10.38% | |
| Buyback Yield / Dilution | -6.07% | -6.07% | -18.01% | -5.62% | -399.27% | -467.09% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.